PRTK
Paratek Pharmaceuticals, Inc.
PRTK
PRTK
Delisted
PRTK was delisted on the 20th of September, 2023.
66 hedge funds and large institutions have $47M invested in Paratek Pharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
44% less call options, than puts
Call options by funds: $146K | Put options by funds: $260K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
66
Holding in Top 10
–
Calls
$146K
Puts
$260K
Top Buyers
| 1 | +$1.69M | |
| 2 | +$1.52M | |
| 3 | +$1.09M | |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$1.06M |
| 5 |
Two Sigma Investments
New York
|
+$876K |
Top Sellers
| 1 | -$6.79M | |
| 2 | -$5.01M | |
| 3 | -$1.67M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$935K |
| 5 |
Morgan Stanley
New York
|
-$454K |